forbes.com
May 9, 2008
The Orphan Drug Act gives pharma companies an extra incentive to work on smaller-market drugs. ... Sometimes, not very often, companies do things that they know won't make them a lot of money, but that will be good for at least a small group of people. Ziopharm Oncology...
[read full story]